Focus Partners Advisor Solutions, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1868872 SAINT LOUIS, MO

Position in REGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,349,964

-$2,737,301 QoQ

Shares Held

2,165

-59.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#593

of 1,322 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Focus Partners Advisor Solutions, LLC holds $11,279,306 across 23 Biotechnology names. REGN ranks #3 (12.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	28,722	$3,255,925
2	EXEL	Exelixis, Inc.	26,603	$1,447,469
3	REGN	Regeneron Pharmaceuticals, Inc. This page	2,165	$1,349,964
4	VRTX	Vertex Pharmaceuticals Inc / Ma	1,708	$848,414
5	BMRN	Biomarin Pharmaceutical Inc	10,899	$623,640
6	CORT	Corcept Therapeutics Inc	6,677	$580,565
7	JAZZ	Jazz Pharmaceuticals plc	1,599	$385,311
8	TGTX	Tg Therapeutics, Inc.	6,261	$343,979

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,349,964	2,165	-59.1%	Shares	Other	2026-08-06
2026-03-31	$4,087,265	5,290	+20.1%	Shares	Other	2026-05-13
2025-12-31	$3,398,543	4,403	+51.4%	Shares	Other	2026-02-11
2025-09-30	$1,635,643	2,909	+242.6%	Shares	Other	2025-11-12
2025-03-31	$538,461	849	+128.8%	Shares	Other	2025-05-15
2024-09-30	$390,010	371	+0.8%	Shares	Other	2024-11-14
2024-06-30	$386,779	368	+75.2%	Shares	Other	2024-08-14
2024-03-31	$202,122	210	-53.4%	Shares	Other	2024-05-15
2022-09-30	$310,680	451	+31.9%	Shares	Other	2022-11-14
2021-12-31	$215,979	342	—	Shares	Other	2022-02-10
No filing history on record for this holder in this stock.